Intrinsiqs

Is Adaptive Biotechnologies Corporation overvalued?

Adaptive Biotechnologies Corporation (ADPT) — key valuation metrics and fundamentals.

No verdict
Price
$29.04
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$4.70B
Dividend yield
0.0%
Return on equity
-37.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ADPT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.